A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer
Precision medicine has emerged as an important paradigm in oncology, driven by the significant heterogeneity of individual patients’ tumour. A key prerequisite for effective implementation of precision oncology is the development of companion biomarkers that can predict response to anti-cancer thera...
Hoofdauteurs: | , , , , , , |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Frontiers Media S.A.
2023-01-01
|
Reeks: | Frontiers in Molecular Biosciences |
Onderwerpen: | |
Online toegang: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1094321/full |